Today: 4 February 2026
Subscribe
Browse Category

NASDAQ:OUST News 5 December 2025

Ouster (OUST) vs Nebius Group (NBIS): Latest News, Analyst Forecasts and Stock Analysis as of December 5, 2025

Ouster (OUST) vs Nebius Group (NBIS): Latest News, Analyst Forecasts and Stock Analysis as of December 5, 2025

The battle for “picks-and-shovels” leadership in next‑generation tech is unfolding in two very different arenas: LiDAR sensors for physical autonomy and AI cloud infrastructure for model training and inference. On one side is Ouster, Inc. (OUST), a fast‑growing LiDAR specialist; on the other is Nebius Group N.V. (NBIS), a hypergrowth AI cloud and “neocloud” provider. As of December 5, 2025,…
5 December 2025
······

Stock Market Today

  • Actinogen Medical and Top ASX Penny Stocks Show Potential Amid Market Headwinds
    February 4, 2026, 3:40 PM EST. The Australian stock market faces pressure from a Reserve Bank rate hike and international tech sell-offs, with ASX 200 futures hinting at a downturn. Yet, ASX penny stocks continue to offer investment opportunities due to their low price points and growth potential. Actinogen Medical (ASX:ACW), a pre-revenue biotechnology firm valued at A$153.2 million, is advancing its Alzheimer's treatment trial and recently secured A$17 million in funding. Despite current unprofitability, Actinogen's innovative approach could spur future revenue growth. Brisbane Broncos Limited (A$181.38 million market cap) operates debt-free in sports management, underlining stability. These stocks exemplify how smaller firms with strong fundamentals may thrive even amid broader market uncertainty.
Go toTop